| Kimberly Danielle Hill, | |
|
1088 Nj-34, Aberdeen, NJ 07747 | |
| (732) 290-1700 | |
| Not Available |
| Full Name | Kimberly Danielle Hill |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1088 Nj-34, Aberdeen, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568058345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Entity Name | Cpc Behavioral Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366497356 PECOS PAC ID: 3971593161 Enrollment ID: O20040518000822 |
News Archive
Researchers at Montclair State University and Kessler Foundation have received funding totaling $651,997 from the National Multiple Sclerosis Society to measure memory-related abilities in individuals with and without multiple sclerosis (MS) for clues to how such cognitive processes are altered by MS. Joshua Sandry, PhD, assistant professor of psychology at Montclair State and Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research at Kessler Foundation, collaborate on the 4-year study, titled "Neuroimaging of Hippocampally Mediated Memory Dysfunction in Multiple Sclerosis."
CDC has formed a committee to consider the equitability of the agency cash awards process in response to analyses that found non-science employees in recent years have received most of the awards, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 9/19).
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
When dealing with coronavirus disease, it is essential for healthcare personnel to wear appropriate personal protective equipment.
Gilead Sciences, Inc. today announced the company is stopping its ongoing Phase II clinical trial of GS 9450, an investigational caspase inhibitor, in patients with chronic hepatitis C. This decision follows reports of significant laboratory abnormalities and adverse events in a number of clinical study participants.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Danielle Hill, 1088 Nj-34, Aberdeen, NJ 07747 Ph: () - | Kimberly Danielle Hill, 1088 Nj-34, Aberdeen, NJ 07747 Ph: (732) 290-1700 |
News Archive
Researchers at Montclair State University and Kessler Foundation have received funding totaling $651,997 from the National Multiple Sclerosis Society to measure memory-related abilities in individuals with and without multiple sclerosis (MS) for clues to how such cognitive processes are altered by MS. Joshua Sandry, PhD, assistant professor of psychology at Montclair State and Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research at Kessler Foundation, collaborate on the 4-year study, titled "Neuroimaging of Hippocampally Mediated Memory Dysfunction in Multiple Sclerosis."
CDC has formed a committee to consider the equitability of the agency cash awards process in response to analyses that found non-science employees in recent years have received most of the awards, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 9/19).
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
When dealing with coronavirus disease, it is essential for healthcare personnel to wear appropriate personal protective equipment.
Gilead Sciences, Inc. today announced the company is stopping its ongoing Phase II clinical trial of GS 9450, an investigational caspase inhibitor, in patients with chronic hepatitis C. This decision follows reports of significant laboratory abnormalities and adverse events in a number of clinical study participants.
› Verified 9 days ago
Ms. Kristen R. Materek, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 | |
Chris Desilvestri, LMFT LCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 506 Laurie Ln, Aberdeen, NJ 07747 Phone: 732-309-6104 | |
Patricia Smith, LSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 | |
Ms. Pennie L. Colleton, NCC, LPC, LCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6 Second Street, Aberdeen, NJ 07747 Phone: 732-744-4406 | |
Alison M D'auguste, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 | |
Donna Coyle, LSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1088 Highway 34, Aberdeen, NJ 07747 Phone: 732-290-1700 Fax: 732-290-0040 | |
Alyssa Tallon, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5 Opal Pl, Aberdeen, NJ 07747 Phone: 732-546-6663 |